Lupin Pharmaceuticals Inc drugs

41 results

  • Atorvastatin calcium (atorvastatin calcium)

    (Atorvastatin Calcium)
    Lupin Pharmaceuticals Inc
    Usage: Atorvastatin calcium is indicated for reducing the risk of myocardial infarction, stroke, and related procedures in adults with risk factors for coronary heart disease, and for lowering LDL cholesterol in patients with hyperlipidemia, familial hypercholesterolemia, and other lipid disorders as an adjunct to diet.

  • Betamethasone dipropionate (betamethasone dipropionate)

    (Betamethasone dipropionate)
    Lupin Pharmaceuticals Inc
    Usage: Betamethasone dipropionate ointment is indicated for the relief of inflammatory and itchy symptoms associated with corticosteroid-responsive skin conditions in patients aged 13 and older.

  • Blisovi fe 1.5/30 ( norethindrone acetate and ethinyl estradiol )

    (norethindrone acetate and ethinyl estradiol)
    Lupin Pharmaceuticals Inc
    Usage: Blisovi Fe 1.5/30 is indicated for pregnancy prevention in women who choose to use oral contraceptives. The drug is effective when used consistently and correctly, significantly reducing the risk of accidental pregnancy compared to other contraceptive methods.

  • Bromfenac (bromfenac)

    (BROMFENAC)
    Lupin Pharmaceuticals Inc
    Usage: Bromfenac ophthalmic solution, 0.075%, is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.

  • Bumetanide (bumetanide)

    (Bumetanide)
    Lupin Pharmaceuticals Inc
    Usage: Bumetanide injection is indicated for treating edema related to congestive heart failure, hepatic and renal diseases, including nephrotic syndrome. It can be administered intravenously or intramuscularly when oral absorption is impaired or impractical, and shows no cross-sensitivity for patients allergic to furosemide.

  • Cefadroxil (cefadroxil)

    (Cefadroxil)
    Lupin Pharmaceuticals Inc
    Usage: Cefadroxil for oral suspension is indicated for treating urinary tract infections, skin and skin structure infections, and pharyngitis/tonsillitis caused by specific bacteria, including E. coli, staphylococci, and Streptococcus pyogenes. It should be used based on culture results to prevent antibiotic resistance.

  • Cefdinir (cefdinir)

    (Cefdinir)
    Lupin Pharmaceuticals Inc
    Usage: Cefdinir capsules are indicated for mild to moderate infections caused by susceptible bacteria, including community-acquired pneumonia, acute bronchitis exacerbations, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections. The drug aims to prevent drug-resistant bacteria development and should be used based on culture and susceptibility data when available.

  • Cefdinir (cefdinir)

    (Cefdinir)
    Lupin Pharmaceuticals Inc
    Usage: Cefdinir for oral suspension is indicated for treating mild to moderate infections caused by susceptible bacteria, including community-acquired pneumonia, acute bronchitis exacerbations, acute sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections. It should be used judiciously to prevent antibiotic resistance.

  • Clarithromycin (clarithromycin)

    (Clarithromycin)
    Lupin Pharmaceuticals Inc
    Usage: Clarithromycin extended-release tablets are indicated for adults to treat mild to moderate infections from susceptible bacteria, specifically for acute bacterial exacerbation of chronic bronchitis, acute maxillary sinusitis, and community-acquired pneumonia. Efficacy for other infections is not established. Susceptibility testing is recommended.

  • Clobetasol propionate (clobetasol propionate)

    (clobetasol propionate)
    Lupin Pharmaceuticals Inc
    Usage: Clobetasol propionate topical solution is indicated for short-term treatment of inflammatory and itchy skin conditions responsive to corticosteroids on the scalp. Treatment should not exceed two consecutive weeks or 50 mL/week due to potential HPA axis suppression. Not recommended for patients under 12 years.